All the latest worldwide HIV and AIDS news, including treatment, prevention, and hepatitis and TB co-infections. News from our own team of writers plus articles we have selected from other sources.

aidsmap hiv & aids news

RSS

← First12345...798Next →

hiv & aids news selected from other sources

  • Harm reduction
    Canada is paving the way to import prescription heroin in bulk
    Vice | 7 hours ago

    Canada’s health minister has said prescribing heroin could help reduce overdose deaths, so Ottawa is allowing large imports of the prescription drug.

  • Hepatitis B
    EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection
    EASL | 10 hours ago

    Hepatitis B virus (HBV) infection remains a global public health problem with changing epidemiology due to several factors including vaccination policies and migration. This Clinical Practice Guideline presents updated recommendations for the optimal management of HBV infection.

  • Global health initiatives
    Three countries get first malaria vaccine
    BBC | 10 hours ago

    The world's first vaccine against malaria will be introduced in three countries - Ghana, Kenya and Malawi - starting in 2018. The four-shot vaccine should prevent four in 10 cases of the disease.

  • Harm reduction
    Healing Austin, Indiana: How town raced to stop America's worst rural HIV plague (three-part series)
    Kentucky Courier-Journal | 10 hours ago

    Critics say Mike Pence was slow to react as a festering blight, then HIV gripped Austin, Indiana. This tiny city off Interstate 65 is the epicenter of a medical disaster. Dr. Tom Frieden, former director of the U.S. Centers for Disease Control and Prevention, confirms Austin contains the largest drug-fueled HIV outbreak to hit rural America in recent history, and "the largest concentrated outbreak ever documented in the United States."

  • BHIVA response to The Irish Times article 'Anti-HIV drug removes personal responsibility'
    BHIVA | 11 hours ago

    This piece has generated a considerable amount of concern in the HIV community already as its content is completely at odds with current recommendations by the World Health Organisation and NICE which recognise that HIV pre-exposure prophylaxis (PrEP) is an important component of HIV prevention. Numerous studies have shown that PrEP is a highly clinically and cost-effective safe intervention which reduces the risk of becoming infected with HIV by around 90%.

  • Hepatitis C
    New hepatitis data highlight need for urgent global response
    World Health Organization | 21 April 2017

    New WHO data reveal that an estimated 325 million people worldwide are living with chronic hepatitis B virus (HBV) or hepatitis C virus (HCV) infection. The WHO Global hepatitis report, 2017 indicates that the large majority of these people lack access to life-saving testing and treatment. As a result, millions of people are at risk of a slow progression to chronic liver disease, cancer, and death.

  • Access to medicines and treatment
    The Medicines Patent Pool and Pharco Pharmaceuticals Sign Licence for Promising Hepatitis C Drug Candidate Ravidasvir
    Medicines Patent Pool | 21 April 2017

    The Medicines Patent Pool (MPP) announced a new licence and technology transfer agreement with Egyptian company Pharco Pharmaceuticals for ravidasvir (RAV), an investigational direct-acting antiviral (DAA) with the potential of working across all six major hepatitis C genotypes. The agreement, signed on the sidelines of the International Liver Congress in Amsterdam, will enable competitive supply of RAV in low- and middle-income countries (LMICs) including high prevalence nations Russia, Ukraine, Egypt and Iran.

  • Prevention of mother-to-child transmission
    The living legacy of the Global Plan: eliminating HIV in children
    UNAIDS | 20 April 2017

    The Journal of Acquired Immune Deficiency Syndromes (JAIDS) has released a special supplement on the incredible journey of the Global plan towards the elimination of new HIV infections among children by 2015 and keeping their mothers alive (Global Plan), which documents the history of the Global Plan and outlines what the future holds as efforts to end AIDS among women, children and adolescents accelerate.

  • PrEP
    Anti-HIV drug removes personal responsibility
    Irish Times | 20 April 2017

    I would argue that Pre-exposure Prophylaxis is a solution which removes personal responsibility in relation to the transmission of HIV, increases the practice of unprotected sexual behaviour and will, ultimately, be responsible for widespread liver disease among gay populations in 10-15 years from now.

  • Hepatitis C symptoms and diagnosis
    Long-term antibiotic prophylaxis reduces mortality in people with advanced liver disease
    EASL press release | 20 April 2017

    A multicenter, randomized, controlled study presented today found that long-term oral antibiotic therapy with norfloxacin improved the prognosis of people with life-threatening advanced liver disease. The study, presented at The International Liver Congress™ 2017 in Amsterdam, The Netherlands, showed that norfloxacin administration for six months was associated with a reduced risk of death and infection at six months in patients with Child-Pugh class C cirrhosis, a very severe and advanced stage of liver disease.

← First12345...1304Next →

Conference news

News from the Conference on Retroviruses and Opportunistic Infections (CROI 2017).

HIV update

Sign up for HIV update, our fortnightly news bulletin for people living with HIV in the UK.

Achieving the 90-90-90 target

With advances in HIV testing, treatment and care, some countries are making great progress towards the UNAIDS 90-90-90 target.

aidsmap news apps

Download the free aidsmap news iPhone and android apps.

Community Consensus Statement on Access to HIV Treatment and its Use for Prevention

Together, we can make it happen

We can end HIV soon if people have equal access to HIV drugs as treatment and as PrEP, and have free choice over whether to take them.

Launched today, the Community Consensus Statement is a basic set of principles aimed at making sure that happens.

The Community Consensus Statement is a joint initiative of AVAC, EATG, MSMGF, GNP+, HIV i-Base, the International HIV/AIDS Alliance, ITPC and NAM/aidsmap
close

This content was checked for accuracy at the time it was written. It may have been superseded by more recent developments. NAM recommends checking whether this is the most current information when making decisions that may affect your health.

NAM’s information is intended to support, rather than replace, consultation with a healthcare professional. Talk to your doctor or another member of your healthcare team for advice tailored to your situation.